Chemours Co
CCCIK 0001627223
Revenue (TTM)
$5.86B
−11.1% YoY
Q1 May 2026
Net Income (TTM)
−$355M
−202.2% YoY
Q1 May 2026
EPS Diluted (TTM)
−$2.36
−200.0% YoY
Q1 May 2026
Gross Margin
16.4%
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
-6.1%
Q1 May 2026
Free Cash Flow (TTM)
−$896M
Q1 May 2026
Cash
$563M
Q1 May 2026
Total Debt
$4.14B
Q1 May 2026
Shares Outstanding
150.38M sh
Q1 May 2026